Androgen receptor drives cellular senescence.
The accepted androgen receptor (AR) role is to promote proliferation and survival of prostate epithelium and thus prostate cancer progression. While growth-inhibitory, tumor-suppressive AR effects have also been documented, the underlying mechanisms are poorly understood. Here, we for the first time...
Main Authors: | Yelena Mirochnik, Dorina Veliceasa, Latanya Williams, Kelly Maxwell, Alexander Yemelyanov, Irina Budunova, Olga V Volpert |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3293868?pdf=render |
Similar Items
-
miR-200b inhibits prostate cancer EMT, growth and metastasis.
by: LaTanya V Williams, et al.
Published: (2013-01-01) -
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
by: Miriam Kokal, et al.
Published: (2020-07-01) -
PPAR𝛾 and Agonists against Cancer: Rational Design of Complementation Treatments
by: Dorina Veliceasa, et al.
Published: (2008-01-01) -
Cellular senescence drives age-dependent hepatic steatosis
by: Mikolaj Ogrodnik, et al.
Published: (2017-06-01) -
Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
by: Thanakorn Pungsrinont, et al.
Published: (2020-04-01)